Dr. WANG Bin serves as a radiation oncologist of Jiahui International Cancer Center. Dr. Wang obtained the bachelor degree of Clinical Medicine from Zhengzhou University School of Medicine in 1999, and then he received the master degree in medical oncology and Ph.D. in pathology at Shanghai Secondary Millitary University. Before joining Jiahui Health, he served as attending physician in the Center of Clinical Oncology, Shenzhen Hospital, Hong Kong University and Department of Radiation at a private cancer center in Shanghai. In 2018, he visited the Cancer Center of Queen Mary Hospital, Hong Kong University and Pamela Youde Nethersole Eastern Hospital. Being a radiation oncologist for more than ten years, he specializes in conventional radiation therapy and stereotactic radiotherapy of various tumors, especially the treatment of gastrointestinal, breast, and head & neck cancers. In addition, he also pays close attention to the cardiac toxicity during breast cancer radiotherapy.

Dr. Wang joined as sub-investigators in a global multi-center clinical trials for liver cancer radiotherapy and a HCC basic research supported by National Natural Science Foundation of China.

He had several academic publications. He had participated in the translation of the English version of Proton Therapy by MDACC and Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy by Nancy Y. Lee.
Dr. Wang is a current member of Chinese Society of Clinical Oncology (CSCO).